Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 FY- Text added to 2021 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
absorbed, aforementioned, analyst, appellate, argument, Asher, ASP, Biden, bioresearch, brainard, Bright, Chron, conflict, coordinated, Cowen, creation, criterion, Cue, Damiba, Darmstadt, Deep, Delta, diana, Dohme, durable, employ, exit, extinguishment, futile, futility, gave, GentiBio, harbor, HITECH, ID, Inspector, instrument, JAVELIN, Kyverna, lawsuit, mathematical, Medley, military, modestly, modification, MOEVNTIG, OIG, Omicron, orderly, Peak, polymeric, predetermined, prejudice, premise, pro, rata, Redwood, reinstate, relaxation, Rescue, Resource, resume, revaluation, Russia, Sharp, shelf, stemming, stream, suing, Synthekine, thirty, UC, Ukraine, unfair, unrest, unstable, vi, vii, voluntarily, waste, Werewolf, whistleblower, Xilio
Removed:
abbreviated, alerting, AMITIZA, anniversary, Apotex, assuring, ASU, auto, awarded, back, backlog, Bayer, biased, BICLA, BILAG, bleeding, bowel, breakdown, bromide, calculated, calling, capable, capitalized, CEO, CFO, chemotherapy, children, chloride, circulation, Clarifying, collaborate, collateral, computation, Congressional, construction, contemplation, continuity, copy, defendant, demonstrated, depleted, Develco, docusate, ELOCTATETM, endeavor, ESPEROCT, estimating, ethnic, exchanged, expiry, Exploratory, expression, extending, feasibility, forecasted, forecasting, fusion, German, glycoPEGylated, halted, ineffective, inflated, infringed, Int, Interaction, interval, Ironwood, JIVI, jury, Korea, lien, listed, live, lubiprostone, magnesia, main, medium, merit, methylnaltrexone, milk, moderately, MSN, Mundipharma, myriad, NE, neutropenia, nivolumab, Notwithstanding, OBD, occurring, OCI, optimizing, Orange, Paragraph, pathogenic, perioperative, phantom, pivotal, preceding, prepaid, Presidential, prevalence, produced, prophylactic, Purdue, purpose, Pvt, randomized, reactive, read, ready, recording, recovered, redemption, reincorporated, reliable, relistor, removed, replaced, rest, retrospectively, Rheumatology, Room, Salix, satisfaction, scheduling, senna, Shionogi, showed, South, stand, stool, suboptimal, superseded, tailored, telephone, Teva, theft, Theravance, UK, underlie, unenforceable, unexpectedly, unsatisfied, updated, validation, version, vigorously, Washington, withheld, withholding
Valuein 2020 FY filing- Value in 2021 FY filing
Original filings
Filing view